The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

NCT00562809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1005

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: IRBESARTAN

Sponsor

Sanofi

Collaborators

[object Object]